Evidence Hub

Breaking the immune "cold niche" in bone metastasis: core mechanisms of the multidimensional interwoven regulatory network and precision breakthrough strategies

Mao Y, Xie F, Chu X, Zhang W, Dou K, Hu B, Fu L, Ding Z et al.

Molecular cancer, 2026

Abstract

Bone metastasis is a pivotal hallmark of advanced malignant tumors. It severely impairs the therapeutic efficacy of immune checkpoint inhibitors (ICIs) and serves as an independent risk factor for poor prognosis of immunotherapy in solid tumors. Most existing reviews are confined to traditional research frameworks and have not yet resolved this clinical dilemma. This paper systematically elaborates on the core mechanisms underlying the poor efficacy of immunotherapy for bone metastasis. It clarifies that the immune suppression mediated by the bone metastatic microenvironment (BME) is not induced by a single factor, but rather a consequence of the cross-regulation of immunity, metabolism, bone matrix, blood vessels, epigenetics, microbiota, and nerves. From seven dimensions-immune cell-mediated immune escape, bone matrix-immune cell crosstalk, vascular-mediated immune suppression, metabolic-immune cross-regulation, epigenetic disorders, microbiota-osteoimmune axis imbalance, and neuro-immune-bone metastasis regulation-the study comprehensively sorts out the key nodes of immunotherapy resistance and clarifies the core cellular, molecular, and microenvironmental interaction mechanisms of this cross-regulatory network. On this basis, this paper explores a multi-target combined therapeutic strategy of "breaking the vicious cycle by targeting key nodes, restoring anti-tumor immunity with ICIs, and realizing local-systemic synergism", including combined bone matrix-immune targeted…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free